CytoSorbents Corporation (CTSO)

[techxen]

I took some notes during the call and screenshots from the presentation which I will post later time permitting here and on ST, because they are worth pointing out.

Probably the most significant thing I took away was the focus on the prevention of bleeding that Dr. Gibson highlighted in much of his presentation. When he says that "Cytosorb is the ONLY strategy that can prevent bleeding in these patients" and he see's a smaller version of the device being used throughout the hospital - not just in the OR, this lends credibility to the potential. He sees the device being used on any patient that is on one of these NOAC's that would be having cardiac electrophysiology procedures, neurosurgical procedures, acute stroke, urgent orthopedic procedures (e.g. broken hip), urgent GI or oncological procedures or trauma.

The reason for a smaller device is that even one as small as 40mL with a lower flow rate can remove up to 96% or more of ticagrelor or rivaroxaban within the first few hours. The doctor from Germany confirmed that only one regular device is needed during cardiac surgery. Having a smaller device means the hospital can use it in any setting and not have to have a bypass pump relocated.

By the way, if you don't know this already the company already makes a small 50mL device - it is called VetResQ :)

https://cytosorbents.com/products/VetResQ/